GSK plc (GSK) adds 70,759 Share Save Plan shares to London listing
Rhea-AI Filing Summary
GSK plc reports that additional ordinary shares have been admitted to trading on the London Stock Exchange Main Market under existing block listing arrangements. The admission relates to the GlaxoSmithKline plc Share Save Plan 2022.
70,759 Ordinary Shares of 31¼ pence each were admitted, increasing the total number of Ordinary Shares admitted to trading to 4,316,292,310. The notification covers the period from 29 May 2026 to 24 July 2026, and the new shares are fully fungible with existing Ordinary Shares.
Positive
- None.
Negative
- None.
Key Figures
Additional shares admitted: 70,759 shares
Total shares after admission: 4,316,292,310 shares
Nominal value per share: 31¼ pence
+1 more
4 metrics
Additional shares admitted
70,759 shares
Further Ordinary Shares admitted to trading under block listing
Total shares after admission
4,316,292,310 shares
Total Ordinary Shares admitted to trading following this admission
Nominal value per share
31¼ pence
Nominal value of each Ordinary Share
Notification date range
29 May 2026 - 24 July 2026
Period covered by the admission to trading notification
Key Terms
block listing admissions, Share Save Plan, fungible, foreign private issuer
4 terms
block listing admissions regulatory
"admitted to trading under existing block listing admissions of Ordinary Shares"
fungible financial
"Fungibility | Fully fungible with existing Ordinary Shares"
Fungible describes an asset that is interchangeable with another of the same kind because each unit holds the same value and function. For investors this matters because fungible assets are easier to trade, price, and store—think of cash or grains where one unit can replace another, unlike a unique artwork or a signed collectible which may be worth more or less depending on provenance. Fungibility affects liquidity, market efficiency, and how assets are settled or regulated.
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What type of securities did GSK (GSK) add to its London listing?
GSK added Ordinary Shares of 31¼ pence each to its London Stock Exchange Main Market listing. The 70,759 new shares admitted are of the same class and are fully fungible with existing Ordinary Shares already trading under ISIN GB00BN7SWP63.